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Contrast-induced nephropathy (CIN) remains a leading cause of iatrogenic acute kidney injury, as the usage of contrast media
for imaging and intravascular intervention keeps expanding. Diabetes is an important predisposing factor for CIN, particularly
in patients with renal functional impairment. Renal hypoxia, combined with the generation of reactive oxygen species, plays a
central role in the pathogenesis of CIN, and the diabetic kidney is particularly susceptible to intensified hypoxic and oxidative
stress following the administration of contrast media. The pathophysiology of this vulnerability is complex and involves various
mechanisms, including a priori enhanced tubular transport activity, oxygen consumption, and the generation of reactive
oxygen species. The regulation of vascular tone and peritubular blood flow may also be altered, particularly due to defective
nitrovasodilation,enhancedendothelinproduction,andaparticularhyperresponsivenesstoadenosine-relatedvasoconstriction.In
addition, micro- and macrovascular diseases and chronic tubulointerstitial changes further compromise regional oxygen delivery,
and renal antioxidant capacity might be hampered. A better understanding of these mechanisms and their control in the diabetic
patient may initiate novel strategies in the prevention of contrast nephropathy in these susceptible patients.
1. Introduction
Contrast-induced nephropathy (CIN) induced by iodinated
contrast media remains a leading cause of inhospital acute
kidney injury (AKI), despite the introduction of new low-
or iso-osmolar agents and the implementation of preventive
measures. This reflects the growing usage of computerized
imaging and intravascular interventions in sicker and older
patients[1].ThepathophysiologyofCINiscomplexandonly
partiallyunderstood.Whiletheroleofadirectnephrotoxicity
affecting tubular cells is debatable, substantial evidence indi-
cates that renal parenchymal hypoxia, particularly within the
renal outer medulla, and the generation of reactive oxygen
species (ROS) play a pivotal role in this disorder, as reviewed
in depth elsewhere [1–3] and illustrated in Figure 1.
While healthy individuals seldom develop CIN, the well-
defined risk factors are associated with increasing likelihood
to acquire this complication. The likelihood of CIN rises
with the number of predisposing factors, and algorithms
were designed to predict the risk of CIN, based on the
presence of these defined predisposing factors [4]. Chronic
kidney disease (CKD) with impaired glomerular filtration
rate (GFR) is the most important intrinsic predisposing
f a c t o r .Th er i s kt od e v e l o pC I Ni sp r o p o r t i o n a lt ot h ed e g r e e
of renal impairment, and in patients with a GFR of about
10–15mL/min, it may exceed 50%. Diabetes is an additional
important risk factor, and for every given baseline GFR in
p a t i e n t sw i t hC K D ,t h ep r e s e n c eo fd i a b e t e sw a sf o u n dt o
double the risk to develop CIN [5]. Multivariate analysis of
database of 8357 patients defined diabetes as an independent
risk factor with an odd ratio of 1.6 [4], and prediabetes
was found to increase the risk of CIN [6]. Since both
renal impairment and diabetes are prevalent among patients
subjected to radiocontrast media, a better understanding of2 BioMed Research International
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Figure 1: Plausible synergic adverse impact of radiocontrast
agents and diabetes upon the kidney, leading to contrast-induced
nephropathy (CIN). Both conditions, diabetes and the administra-
tion of iodinated radiocontrast agents, lead to altered renal physio-
logic processes (in yellow): there is an excess formation of reactive
oxygen species (ROS) and altered renal oxygenation, related to
disregulatedrenalmicrocirculationandenhancedtubulartransport
and oxygen consumption. Evolving renal parenchymal hypoxia and
enhanced ROS formation lead to tubular and vascular endothelial
injury, with subsequent reduction of glomerular filtration rate
(GFR),thehallmarkofCIN.Conceivableinteractionsbetweenthese
processes are outlined by arrows and discussed in depth in the text.
In brief, both diabetes and contrast agents enhance ROS formation.
They also hamper renal oxygenation, either directly or through
increased generation of ROS. Vascular endothelial cell injury may
further amplify renal hypoxia via a feed-forward loop of altered
microcirculation (green arrow).
the nature of this disorder, particularly in their presence, is
important and is the objective of this review.
2. Renal Hypoxia and Oxidative Stress and
Their Role in CIN
The special structure of the renal medulla, designed for
urinary concentrating capability, is the cause for low
outer medullary oxygen tension (pO2), at the range of
30–40mmHg under normal physiologic conditions. Low
medullary oxygenation reflects intense tubular transport
(particularly by medullary thick limbs, mTALs) in a region
with limited blood and oxygen supply [7]. Highly effi-
cient neurohumoral mechanisms maintain barely balanced
medullary oxygenation by matching regional tubular trans-
port activity and blood supply. Medullary tubular transport
activity is governed by solute delivery to the distal nephron
(determined by GFR and proximal tubular transport) and by
the direct regulation of mTAL transporters, particularly Na-
K ATPase. Blood and oxygen supply, delivered through per-
itubular capillaries, depends on limited blood flow through
vasa recta that emerge from juxta-medullary nephrons.
Adenosine, nitric oxide (NO), prostaglandins (particularly
PGE2 and PGI2), and other agents maintain medullary
oxygenation by reducing transport activity, by enhancing
regional blood flow, or by a combination of both [7, 8].
As reviewed in depth [1, 2], the intravascular adminis-
tration of all types of iodinated radiocontrast agents further
reduces medullary pO2 to levels as low as 15–20mmHg.
This has been clearly documented under experimental set-
tings with oxygen microelectrodes, by the detection of
pimonidazoleadducts(whichbindtotissueswithpO2 below
10mmHg) or by the regional accumulation of hypoxia-
inducible factors (HIFs). HIFs are key regulators of cellular
response to hypoxic stress, controlling the expression of
numerous genes involved in cell metabolism, proliferation,
a n ds u r v i v a la n di nt h es t r u c t u r ea n df u n c t i o no fr e g i o n a l
microcirculation.Underphysiologicconditions,HIFsubunit
𝗼 undergoes proteasomal degradation, initiated by oxygen-
sensitive HIF-prolyl hydroxylases. Intensified hypoxia de-
activatesHIF-prolylhydroxylases, leading to HIF-𝗼accumu-
lation and its binding to HIF-𝗽 s u b u n i t s .Th ef o r m e dH I F -
𝗼𝗽 heterodimer undergoes nuclear translocation, binds to
hypoxia-response elements (HRE) along the DNA strands,
and initiates transcriptional responses [9]. Indeed, nuclear
HIF expression has been detected in medullary structures
following the administration of radiocontrast media [10],
indicating the induction of cellular hypoxic stress response
by contrast agents.
Importantly, this is a sublethal form of hypoxic stress
[11], since it does not lead to structural damage or to
renal dysfunction in intact animals. This resembles healthy
individuals that hardly ever develop CIN. By contrast, CIN
may develop when animals are preconditioned by measures
that mimic clinical conditions predisposing to CIN [2, 12].
Since many of these comorbidities are characterized by
altered regulatory systems that maintain medullary regional
oxygenation during hypoxic stress, simplified animal models
were developed such as the inactivation of cyclooxygenase
and NO synthase (NOS) prior to radiocontrast injection
[13]. In these models, inhibition of prostaglandin or NO
synthesis abolishes outer medullary vasodilatory response to
the radiocontrast and intensifies medullary hypoxia, leading
toAKIwithoutermedullaryhypoxicdamage.Tubularinjury,
ranging from apoptosis to frank necrosis, mostly affects
mTALs in the inner stripe of the outer medulla. However,
in the most severe models damage may extend outwards to
t h eo u t e rs t r i p ea n dm e d u l l a r yr a y sa n di n w a r d si n t ot h e
papilla,involvingS3segmentsoftheproximaltubules,aswell
as thin limbs, and collecting ducts, respectively. Within the
outer medulla, a peculiar gradient of hypoxic injury is noted,
increasing from the better oxygenated region around vasa
recta to the mid-interbundle zone, most remote from oxygen
supply [1, 12].
Th ec o m p l e xm e c h a n i s m si n v o l v e di nt h ed e c l i n ei n
medullary oxygenation following the administration of con-
trast media are discussed in depth elsewhere [1, 2]. In brief,
on one hand, oxygen consumption for tubular transport may
increase due to a transient surge in GFR and the diuresis fol-
lowingradiocontrastadministration.Furthermore,enhanced
ROSformationincreasesmTALtransportactivityandoxygen
expenditure (see below). On the other hand, medullary
regional microcirculation and oxygen delivery decline, asBioMed Research International 3
the result of increased interstitial pressure with capillary
collapse and due to altered regulation of vascular tone. This
later phenomenon is believed to be principally related to
an increase in adenosine generation and endothelin syn-
thesis and to a decline in NO availability [1, 2]. Finally,
direct endothelial cell injury, with extravasation of red blood
cells, has recently been noted in the inner stripe of the
outer medulla of mice subjected to contrast agents [14]
complementing previous findings of radiocontrast-induced
endothelial cell damage in vitro [15]. The only precondi-
tioning in these animals was dehydration. These findings
raise the possibility that hypoxic or toxic damage to vascular
endothelial cells may also play a pivotal role in the evolution
of medullary hypoxia under certain settings.
As reviewed elsewhere in depth [1, 3], the administration
of contrast media results in enhanced formation of ROS and
with oxidative and nitrosative stress that likely participate in
thepathogenesisofCIN.Conceivably,itisthecombinationof
enhanced transport activity and hypoxia that generates ROS,
as most in vitro studies with renal cells or isolated nephron
segments failed to demonstrate a direct impact of radiocon-
trastuponROSgeneration.ROSalterrenalmedullaryoxygen
balance by both the enhancement of tubular transport and
oxygen consumption and by disrupting nitrovasodilation.
The importance of ROS in the alteration of renal micro-
circulation is underscored by the in vitro amelioration of
radiocontrast-induced vasa recta constriction in response to
antioxidants [16].
3. Evidence for Intensified Hypoxia and
Oxidative Stress in the Diabetic Kidney
The predisposition of the diabetic kidney to CIN might be
related to intensified renal hypoxia and oxidative stress, as
reviewed in depth in [17]. Indeed, experimental diabetes is
associated with reduced renal pO2. Using oxygen microelec-
trodes, Palm and colleagues [18] demonstrated lower renal
parenchymal pO2 in diabetic rats, as compared with control
animals, both in the cortex (about 36 versus 50mmHg) and
inthemedulla(around11versus27mmHg).Thisobservation
wasalsoconfirmednoninvasivelywithBOLDMRI,detecting
increasing concentrations of deoxygenated hemoglobin in
the outer medulla in diabetic animals [19, 20]. Furthermore,
pimonidazole adducts (which indicate a pO2 <10mmHg)
were detected in the renal outer medulla and papilla in
rats within 7 days after the induction of diabetes with
streptozotocin, while untreated controls had no evidence
of pimonidazole accumulation. Evolving medullary hypoxia
was associated with HIF stabilization in these regions, indi-
cating tissue reaction to hypoxic stress [21]. Chronic HIF
stimulation in the diabetic kidney may also be triggered by
regional inflammation [22, 23].
Diabetes is associated with enhanced ROS formation,
which is believed to play an important role in diabetic
nephropathy.Asdiscussedindepthelsewhere[17],enhanced
ROS in thediabetic kidneyis principallydue to theincreased
activity of NADPH oxidase and the augmented mitochon-
drialgenerationofsuperoxide,relatedtoincreasedmetabolic
activity and the glycation of mitochondrial proteins. Activa-
tionoftherenin-angiotensinaxismayalsointensifyNADPH
oxidase in the diabetic kidney [17].
4. Mechanisms of Augmented Hypoxia in the
Diabetic Kidney: Enhanced
Oxygen Consumption
As thoroughly reviewed elsewhere [24], enhanced oxygen
consumption for tubular solute reabsorption is a major
determinant in the development of hypoxia in the diabetic
kidney. Early diabetes is associated with a marked increase in
GFR, in parallel with kidney growth and increased glomeru-
lar and tubular mass, either by hyperplasia or hypertrophy
[25], implying greater oxygen utilization. Increased solute
delivery to the nephron, augmented tubular transport, and
oxygen consumption reflects enhanced GFR and osmotic
diuresis [1, 2]. Indeed, in analogy, experimental renal hyper-
trophy, induced by uninephrectomy or with high protein
diet, enhances renal medullary Na-K-ATPase content and
predisposes to outer medullary hypoxic injury in isolated
rat kidneys, perfused with red-cell-free oxygenated medium
[26].Prioruninephrectomywithhypertrophyoftheremnant
kidney was also found to be an important independent
contributor to the development of AKI in vivo in rats
subjected to salt depletion, indomethacin, and radiocontrast
[27]. An injury pattern was noted, comparable to that in the
isolated perfused kidney, principally with mTAL necrosis in
t h eo u t e rm e d u l l a .I nt h es a m em a n n e r ,a c u t e l ye n h a n c i n g
GFR with the infusion of glycine resulted in augmentation
of outer medullary injury and renal dysfunction in the same
experimental model of CIN [28].
It is tempting to assume that in advanced diabetic
nephropathy with reduced numbers of nephrons, oxygen
consumption for tubular transport per remnant nephron
might be larger, with a greater risk for the develop-
ment of critical hypoxia. Hyperglycemia and diabetes
increase Na/glucose-linked transporters; enhance expres-
sion of uncoupling protein-2; and augment free fatty acid
metabolism, gluconeogenesis, and glycogen synthesis, hence
increasing oxygen consumption by tubular cells [17, 22]. Fur-
thermore, increased ROS generation in the diabetic kidney
enhances Na-K-2Cl cotransport activity, as shown in isolated
mTALs [29], while impeding electrolyte transport efficacy
(i.e., more oxygen demand per transport load) [22, 24].
Indeed, Palm et al., exploring the diabetic kidney, found
that the addition of antioxidants reduced tubular oxygen
consumption in vitro and attenuated renal parenchymal
hypoxia in vivo [18]. Thus, in the diabetic kidney a feed-
forward loop likely exists, of regional hypoxia, enhanced
ROS generation, and increased tubular transport, which
further amplifies regional hypoxia. The administration of
contrast media may step up this devastating process in the
diabetickidneybyfurtherintensificationofhypoxiaandROS
formation.4 BioMed Research International
5. Mechanisms of Augmented Hypoxia in the
Diabetic Kidney: Altered Oxygen Supply
Macrovascular disease and chronic tubulointerstitial changes
likelycompromiseoxygendeliveryanddiffusioninadvanced
diabetes and diabetic nephropathy, hence predisposing to
CIN. In addition, it is tempting to assume that diabetic
autonomicneuropathydisruptsthecapacitytopreserverenal
perfusion pressure and alters renal innervation involved in
the maintenance of intrarenal distribution of blood flow
and oxygen supply. An additional plausible mechanism for
intensified hypoxia in the diabetic kidney is an increase in
oxygen shunt from descending to ascending vasa recta, as
a result of the Bohr effect, related to reduced interstitial pH
[30].
Furthermore, the regulation of various mediators which
determinerenalvasculartoneandmicrocirculationareham-
peredinthediabetickidney,leadingtoagreatersusceptibility
to the development of critical hypoxia following the admin-
istrationofcontrastmaterial.Principalfactorslikelyinvolved
are faulted nitrovasodilation,enhanced endothelin synthesis,
and increased effect of adenosine.
5.1. Altered NO Generation. The complex interplay between
N O ,R O S ,a n do x y g e ns u p p l ya n du t i l i z a t i o n[ 17, 31]i s
beyond the scope of this review. Yet, importantly, as noted
above, the diabetic kidney is characterized by enhanced ROS
generation, altered NO response, and reduced pO2.R e n a l
medullary NO is low in the diabetic kidney [18, 32]. Con-
ceivably, increased ROS generation reduces NO availability
in these settings through its scavenging, with the formation
of the highly toxic peroxynitrite. Additional contributors to
NO depletion in the diabetic kidney are NOS uncoupling,
reduced membranal eNOS activity, and increased levels of
PKC, ADMA, and intracellular arginase with consequent L-
arginine depletion [17, 32].
Renal NO abruptly rises in the normal rat kidney follow-
ing radiocontrast injection [33], and its significance in main-
taining renal oxygenation in these settings is underscored by
the conversion of medullary vasodilatory response into vaso-
constrictionfollowingtheadministrationofradiocontrast,at
the presence of NOS inhibition [13]. Palm et al. noted that
the administration of antioxidants not only reduced oxygen
consumptionfortubulartransportinthediabetickidney,but
also somewhat improved outer medullary microcirculation
[18]. Thus, ROS-mediated NO depletion might be harmful to
the renal microcirculation following radiocontrast adminis-
tration, especially in the diabetic kidney.
5.2. Increased Endothelin Synthesis. The administration of
contrast media is associated with increased plasma levels of
endothelin-1 (ET-1) under experimental settings [34]. ET-1
levels also increase following radiocontrast administration
and are higher both at baseline and following radiocontrast
in diabetics and in patients with CKD [35]. Diabetes is
associated with enhanced synthesis of the pre-pro-hormone.
In addition, endothelin-converting enzyme (ECE)-1, which
catalyzes the conversion of the prohormone to the active
c o m p o u n dE T - 1 ,i sa l s ou p r e g u l a t e di nd i a b e t e s .E x p e r i m e n -
t a ld i a b e t e si nr a t sr e s u l t e di nafi v e f o l di n c r e a s ei nE C E -
1 expression in the outer medulla, and a 15-fold increment
wasnotedindiabeticratssubjectedtocontrastmedium[36].
Conceivably, radiocontrast-induced enhanced production
of ET-1, particularly in the diabetic kidney, by both the
induction of prehormone and ECE-1 synthesis, participates
in microvascular dysregulation and in the development of
CIN. PKC, activated in diabetes [37], is a known mediator of
ECE-1 activation [38]. Furthermore, ECE-1 is likely a HIF-
target gene [39], and possibly enhanced medullary ECE-1
is triggered by HIF, induced by both diabetes and contrast
media.
5.3. Altered Generation and Action of Adenosine. As outlined
thoroughlyelsewhere[40],adenosinehasamarkedinfluence
upon renal parenchymal oxygenation, playing a central role
in the tubuloglomerular feedback mechanism, affecting both
tubular transport activity and the renal microcirculation.
The effects of adenosine are highly complex and depend on
the distribution and action of its receptors, on adenosine
concentrations, and on the duration of receptor stimulation.
Adenosine-induced enhancement of proximal tubular reab-
sorption and inhibition of mTAL transport activity improve
medullary oxygenation. However, its microvascular effects
aremorecomplexregardingmedullaryoxygenation,exerting
both vascular constriction (via adenosine A1 receptors) and
vascular dilatation (stimulated by adenosine A2 receptors).
Some vascular beds, such as descending vasa recta, express
both types of receptors [40]. The diverse and complex effects
of adenosine on the renal microcirculation can be demon-
strated by its exogenous administration in the presence of
selective adenosine inhibitors, illustrating an overall reduc-
tion of cortical microcirculation and oxygenation and ame-
lioration of medullary hypoxia [41]. Yet endogenously gener-
ated adenosine may exert quite different vascular responses,
and altered NO synthesis or increased angiotensin II might
modify their overall activity, potentiating vasoconstriction
[40].
Adenosine, generated following radiocontrast adminis-
trationbyATPbreakdowninthehypoxickidney,conceivably
participates in the pathogenesis of CIN. Indeed, adenosine
nonselective or A1 receptor-selective blockers or knock-out
manipulations were found to blunt the decline in renal blood
flow and GFR and to attenuate CIN in experimental models
and in humans [42–52].
Endogenous generation of adenosine might be modified
in the hypoxic diabetic kidney, and its effects upon renal
microcirculation and oxygenation may be altered, particu-
larly in the presence of altered NO and enhanced AII syn-
thesis. Indeed, exogenous adenosine was found to markedly
intensify renal vasoconstriction in diabetic rats as compared
with intact animals [53]. Furthermore, as compared to intact
controls, diabetic animals displayed attenuation of vasocon-
strictive response to adenosine following the inhibition of
prostaglandin [54]o rN Os y n t h e s i s[ 55], suggesting a dimin-
ished vasodilatory capacity of NO or prostaglandins (PGE2,
PGI2) to counteract adenosine-induced vasoconstriction.BioMed Research International 5
6. Contrast Nephropathy in the Diabetic
Kidney: Controversies and Pitfalls
As outlined above, the propensity to develop CIN in the
diabetic kidney might be related to both lower baseline
medullary pO2 and enhanced ROS formation, with altered
tubular cellular metabolism and microcirculation. It is antic-
ipated that radiocontrast administration, also characterized
by hypoxic and oxidative stress, by its own should further
amplify renal hypoxic and oxidative stress in the diabetic
kidney.Yet,fewobservationsdonotfitwellwiththisconcept,
underscoring the complexity of these settings.
There are many confounders both in clinical and exper-
imental settings that may blur our understanding, such as
the type and duration of diabetes, and the degree of renal
impairmentandmicrovascularcompromise.Inexperimental
settings, interspecies differences and the model types of
diabetes and CIN might play a role. In both experimental
and clinical studies, there is an impact of the type of contrast
media, their volume and mode of administration, additional
comorbidities such as renal failure at various stages, the
administration of preventive measures, and other factors
involved that are yet to be defined.
As an example for an impact of progression of dia-
betes along time, in streptozotocin-induced diabetes in rats,
r e n a lc o r t i c a lb l o o dfl o wa n dG F R( a n dc o n c e i v a b l yo x y g e n
demand for tubular transport) are initially increased, but
decline by 4–9 weeks. Accordingly, intensified medullary
hypoxia; enhanced pimonidazole immunostaining; and HIF
expression, noted at earlier time points, tend to decline
over time [21, 56]. At this later time point, radiocontrast
administration, though altering medullary blood flow, did
not further reduce medullary pO2,a so p p o s e dt oam a r k e d
decline in control animals [56].
Thepotentialconfoundingimpactofpreventivemeasures
is illustrated in a clinical trial in patients with CKD, where
renal blood flow, lower at baseline in diabetics, as compared
with patients with comparable renal impairment, increased
more profoundly during coronary angiography in response
to renal vasodilators [57].
Additional potential confounder is chronic hypoxia
adaptation in the diabetic kidney that might confer tol-
erance to hypoxic and oxidative stress and modify the
phenotype of CIN. Unexpectedly, diabetic rats subjected to
contrast medium following cyclooxygenase inhibition with
indomethacin displayed only rare and focal mTAL injury in
theinnerstripeoftheoutermedulla,andthedegreeofkidney
impairment was comparable to nondiabetic animals [58]. By
contrast, diabetic kidneys perfused with cell-free oxygenated
medium (intense hypoxic conditions) exhibited most severe
hypoxic damage, as compared with moderate and reversible
outer medullary injury in control kidneys [58]. We hypoth-
esized that hypoxia preconditioning in the diabetic kidney,
with upregulation of HIF signals and the expression of reno-
protectiveHIF-dependentgenes[21],mightmitigatehypoxic
damage caused by contrast media, but not under extreme
hypoxic stress, as occured in the isolated perfusion system.
This observation bears resemblance to the unexpected renal
medullary protection against hypoxic injury in experimental
CIN in animals with chronic tubulointerstitial disease, char-
acterized by rarefaction of peritubular capillaries, medullary
hypoxia and HIF induction [59]. In these settings, a more
pronounced rise in plasma creatinine in CKD rats following
a CIN protocol, at the absence of a morphologic counterpart,
likely reflects disruption of renal hemodynamic adaptive
mechanisms that at baseline compensate for the structural
changes.
As the studies detailed above illustrate a potential dichot-
omy between changes in GFR and renal structural damage,
a true assessment of the efficacy of preventive strategies in
CIN in diabetic patients, outlined below, might be better
understood by the determination of urine biomarkers of
tubular damage [60].
7. Renal Hypoxic and Oxidative Stress in the
Diabetic Kidney Subjected to Radiocontrast:
Therapeutic Implications
Enhancement of GFR has been tried in the prevention of
CIN. As reviewed above, this approach may enhance solute
delivery for reabsorption along the nephron, hence more
transport activity and oxygen consumption. This approach
might be especially hazardous in the diabetic kidney, prone
to a more profound hypoxic and oxidative stress. Indeed, in
few clinical trials, enhancing GFR and diuresis was found to
adversely affect kidney function in diabetic patients under-
going coronary angiography. In a small study by Weisberg et
al. the administration of dopamine, atrial natriuretic factor
(ANP) or mannitol to patients with CKD, resulted in a
30–50% increment in plasma creatinine in diabetics, but
not in nondiabetic individuals [57]. Likewise, diabetics were
p a r t i c u l a r l ys u s c e p t i b l et od e v e l o pC I Nw h e ng i v e na nA N P
analogue in a randomized well-controlled study by Kurnik
et al. [61]. Two-hundred and forty seven patients with CKD
undergoing radiocontrast studies were enrolled, half of them
were diabetics. The incidence of CIN among nondiabetics
was comparable in patients given saline or saline + ANP (9%
and 8%, resp.). By contrast, among diabetics, ANP treatment
tended to enhance the risk of CIN (26% versus 39%, resp.).
However, thepotentialcontributionofvolumedepletionand
prerenal azotemia to the special susceptibility of diabetics
in the above studies was not unequivocally excluded. Future
experiments applying strict control of euvolemia, as recently
conducted in the Remedial II trial [62], are required to
address this debate.
In the same fashion, the role of adenosine-receptor
blockers in the prevention of CIN, based on studies show-
ing enhanced renal blood flow and GFR warrants further
consideration, since adenosine helps to maintain medullary
oxygenation (though at the price of reduced GFR). Indeed,
Liss and colleagues found that in normal rats medullary
oxygenation fell by 24% with adenosine [63], and such an
effect might be especially hazardous in the diabetic kidney.
Endothelin receptor antagonists in particular endothelin
ETA receptor blockers might also be useful in the prevention
ofCIN[64],particularlyindiabeticpatients,characterizedby6 BioMed Research International
markedlyenhancedendothelinsynthesisfollowingradiocon-
trast administration [35, 36]. Interestingly, preliminary stud-
ies looking at the urine excretion of neutrophil gelatinase-
associated lipocalin (NGAL) suggest the attenuation of distal
t u b u l a ri n j u r yi nd i a b e t i cp a t i e n t se v e ni nt h ea b s e n c eo f
exposure to radiocontrast agents [65].
Osmotic diuresis in uncontrolled diabetes theoretically
might help excretion of contrast media and lower its concen-
tration in the tubular lumen, decreasing urine viscosity and
consequently reducing interstitial pressure and microvascu-
lar compromise. However, appropriate generous hydration
seems to be warranted particularly in these setting to com-
pensate for fluid deficit and to achieve sufficient volume
expansion.
Since enhanced transport activity and oxygen consump-
tion are a principal cause of renal hypoxia in the diabetic
kidney ,theuseofloopdiuretics,whichamelioratesmedullary
hypoxia [66] and hypoxic damage in experimental contrast
nephropathy [67], with careful fluid replacement to avoid
volume depletion [62], might be renoprotective, particularly
in diabetics, but this has yet to be evaluated.
Dyslipidemia is common among diabetic patients, and
hypercholesterolemia has been identified as a predisposing
factor to CIN in experimental AKI, characterized by com-
promised NO synthesis and enhanced ROS generation [68].
Interestingly, a loading dose of atorvastatin was recently
found to attenuate the risk for CIN in CKD patients treated
with NAC and bicarbonate. Yet, this effect was comparable
among diabetic and nondiabetic individuals, and the mecha-
nisms of renal protection might not involve lipid metabolism
[69].
The administration of the antioxidant N-acetylcysteine
and bicarbonate infusion are controversial strategies in the
prevention of CIN [1–3]. The use of antioxidants in the
prevention of CIN is particularly reasonable in diabetic
patients, characterized by a priori enhanced ROS generation.
IncreasingrenalparenchymalpHisalsoreasonableespecially
inthediabeticpatientinordertoreduceoxygenshuntacross
vasa recta. Antioxidants may also improve hypoxic stress
response through HIF stabilization [21], which might be
renoprotective. Yet, an effect of such strategies has not been
explored specifically in diabetic patients, and this might be
an objective in future clinical trials. Administration of L-
arginineseemstobeanadditionalplausibleoptionindiabetic
patientspriortoradiocontraststudies, asitsdeficiency might
contribute to renomedullary hypoxia [32].
8. Conclusions
Diabetes and the administration of iodinated radiocon-
trast agents are both associated with marked alterations
of renal physiology, including changes in GFR and renal
hemodynamics, enhanced tubular transport activity and
oxygenexpenditureandintensificationofmedullaryhypoxia,
and ROS generation. Diabetes conceivably predisposes to
CIN principally through the amplification of these changes
and the disruption of protective mechanisms, designed to
maintain medullary oxygenation and to ameliorate oxidative
stress. The efficacy of preventive measures in clinical trials in
CKD patients should be separately assessed for this subgroup
of diabetic individuals.
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